Vertex Research Group Inc — research payments reported

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$1,500	1
2023	Research	$25,833	4

Breakdown

Who paid Research payments · program years 2023–2024

AbbVie, Inc. $10,583 2 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $9,500 1 payment
Biohaven Pharmaceutical Holding Company Ltd. $5,750 1 payment
Pfizer Inc. $1,500 1 payment

Studies the money was for Research payments · program years 2023–2024

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimers Disease $10,583 2 payments
Connex 1 $9,500 1 payment
A Phase 3 Randomized Doubleblind Placebocontrolled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents 6 to 18 Years of Age $7,250 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.